A landmark 'evolutionary double-bind' strategy to overcome treatment resistance in prostate cancer

Many patients with metastatic cancers receive therapy that is initially highly effective, often resulting in complete remission. However, cancer cells have a remarkable capacity to evolve resistance to currently available therapies. As a result,…

Continue Reading

News Source: medicalxpress.com